The surgery was done for a college-aged athlete who had chronic pain from a previous meniscectomy, according to a Feb. 6 news release. RejuvaKnee, developed by Regenity Biosciences, has FDA clearance and has been shown to support a more complete recovery by facilitating regeneration of native meniscus tissue.
Dr. Fleissner plans to perform more meniscus repairs with the implant, the release said.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
